Showing results for Collaborations

Three Indiana University School of Medicine researchers and their collaborators at Purdue University have been awarded pilot grants through the Engineering in Medicine program, a ...

A study of Indianapolis patients found providing personalized health information did not increase colorectal cancer testing rates. 

A new study found that AI could predict more accurate vital sign goals for ICU patients, leading to better outcomes. 

The IU School of Medicine has several programs dedicated to Alzheimer's disease research, from basic and translational science to clinical research and innovation.

A new study measured AI’s effectiveness at identifying the most deadly type of brain tumor. 

The new strategic leadership role will collaborate with faculty across the school, IU Health and IU-LAB to advance clinical trial participation.

IU School of Medicine researchers aim to develop a new treatment for neurodegeneration by targeting an immune cell-specific gene associated with Alzheimer's disease.

IU School of Medicine researchers have identified a portfolio of novel drug targets that may accelerate promising treatments for people living with Alzheimer’s disease.

IU School of Medicine researchers are studying how rapid DNA sequencing technology can help improve treatment for fracture-related infections, a serious health complication that can ...

A trio of studies led by IU School of Medicine researchers found digital testing during primary care visits showed some promise as a tool for early identification of Alzheimer’s disease and dementia in older adults.